Peoria Fire Captain Jeremy Gibbons returned to the job after undergoing brain surgery. Walking through the doors at Fire ...

(Alliance News) - CRISM Therapeutics Corp on Tuesday said it has established a scientific advisory board as it prepares to submit a clinical trial application for its lead product, ChemoSeed. Shares ...

Exercise is already recommended to improve so many aspects of our health. Now, researchers believe it could be crucial in ...

Brantley Odom was diagnosed in 2023 with medulloblastoma, a rare and aggressive form of brain cancer. For nearly two years, ...

The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

INB-200 is well-tolerated, showing no serious toxicities beyond those typically observed with chemotherapy. Importantly no cytokine release syndrome (CRS), or immune effector cell-associated ...

There is no cure; the best we can do is supportive care and try to limit some of the worst effects. So, please, if a child ...

There is no cure; the best we can do is supportive care and try to limit some of the worst effects. So, please, if a child ...

I was in Chicago this weekend attending the ASCO meeting, the largest oncology meeting in the world. Nary a talk or poster ...

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...